Ocugen Statistics

Total Valuation

Ocugen has a market cap or net worth of $381.03 million. The enterprise value is $381.43 million.

Market Cap	381.03M
Enterprise Value	381.43M

Important Dates

The last earnings date was Wednesday, November 5, 2025, before market open.

Earnings Date	Nov 5, 2025
Ex-Dividend Date	n/a

Share Statistics

Ocugen has 312.32 million shares outstanding. The number of shares has increased by 12.36% in one year.

Current Share Class	312.32M
Shares Outstanding	312.32M
Shares Change (YoY)	+12.36%
Shares Change (QoQ)	+4.09%
Owned by Insiders (%)	1.49%
Owned by Institutions (%)	14.67%
Float	307.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	66.98
Forward PS	151.24
PB Ratio	107.85
P/TBV Ratio	107.85
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	71.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 9.33.

Current Ratio	1.85
Quick Ratio	1.60
Debt / Equity	9.33
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-16.16

Financial Efficiency

Return on equity (ROE) is -289.93% and return on invested capital (ROIC) is -90.71%.

Return on Equity (ROE)	-289.93%
Return on Assets (ROA)	-63.67%
Return on Invested Capital (ROIC)	-90.71%
Return on Capital Employed (ROCE)	-163.53%
Revenue Per Employee	$56,526
Profits Per Employee	-$673,895
Employee Count	95
Asset Turnover	0.09
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.13% in the last 52 weeks. The beta is 4.54, so Ocugen's price volatility has been higher than the market average.

Beta (5Y)	4.54
52-Week Price Change	+38.13%
50-Day Moving Average	1.45
200-Day Moving Average	1.03
Relative Strength Index (RSI)	44.20
Average Volume (20 Days)	3,231,839

Short Selling Information

The latest short interest is 59.09 million, so 18.92% of the outstanding shares have been sold short.

Short Interest	59.09M
Short Previous Month	58.01M
Short % of Shares Out	18.92%
Short % of Float	19.24%
Short Ratio (days to cover)	16.08

Income Statement

In the last 12 months, Ocugen had revenue of $5.37 million and -$64.02 million in losses. Loss per share was -$0.22.

Revenue	5.37M
Gross Profit	-32.00M
Operating Income	-60.89M
Pretax Income	-64.02M
Net Income	-64.02M
EBITDA	-57.51M
EBIT	-60.89M
Loss Per Share	-$0.22

Full Income Statement

Balance Sheet

The company has $32.57 million in cash and $32.96 million in debt, giving a net cash position of -$399,000 or -$0.00 per share.

Cash & Cash Equivalents	32.57M
Total Debt	32.96M
Net Cash	-399,000
Net Cash Per Share	-$0.00
Equity (Book Value)	3.53M
Book Value Per Share	0.01
Working Capital	17.28M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$53.37 million and capital expenditures -$163,000, giving a free cash flow of -$53.53 million.

Operating Cash Flow	-53.37M
Capital Expenditures	-163,000
Free Cash Flow	-53.53M
FCF Per Share	-$0.17

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,133.87%
Pretax Margin	-1,192.18%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Ocugen does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-12.36%
Shareholder Yield	-12.36%
Earnings Yield	-16.80%
FCF Yield	-14.05%

Analyst Forecast

The average price target for Ocugen is $7.00, which is 473.77% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$7.00
Price Target Difference	473.77%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	173.82%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Ocugen has an Altman Z-Score of -9.61 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.61
Piotroski F-Score	2